Back
Alaunos Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
TCRT
Sponsored
Do you own any of the "SELL" rated stocks on this list?
Go here now to get free instant access to all 20 stocks to sell.
Sell
20
TCRT
Alaunos Therapeutics
Last Price:
3.31
Seasonality Move:
-7.2%
7 Day Trial
ALL ACCESS PASS
$
7
Wall St Issues Rare "SELL" alert
MarketBeat is making the full list completely FREE for a limited time.Alaunos Therapeutics Price Quote
$3.31
+0.19 (+6.09%)
(Updated: September 24, 2024 at 5:30 PM ET)
Alaunos Therapeutics Key Stats
Sell
20
Alaunos Therapeutics (TCRT)
is a Sell
Day range:
$2.74 - $3.20
52-week range:
$2.07 - $32.85
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.32%
Volume:
38.6K
Avg. volume:
20.4K
1-year change:
-83.62%
Market cap:
$5M
Revenue:
$5K
EPS:
$-12.71
How Much Does Alaunos Therapeutics Make?
Data Unavailable
Is Alaunos Therapeutics Growing As A Company?
-
What Is Alaunos Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0% -
What Is Alaunos Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Alaunos Therapeutics Stock Price Performance
-
Did Alaunos Therapeutics Stock Go Up Last Month?
Alaunos Therapeutics share price went up by 9.86% last month -
Did TCRT's Share Price Rise Over The Last Year?
TCRT share price fell by -83.62% over the past 1 year
What Is Alaunos Therapeutics 52-Week High & Low?
-
What Is Alaunos Therapeutics’s 52-Week High Share Price?
Alaunos Therapeutics has traded as high as $32.85 over the past 52 weeks -
What Is Alaunos Therapeutics’s 52-Week Low Share Price?
Alaunos Therapeutics has traded as low as $2.07 over the past 52 weeks
Alaunos Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Alaunos Therapeutics?
-
How Much Debt Does Alaunos Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Alaunos Therapeutics Have?
Cash and short term investments quarterly total is $2.5M -
What Is Alaunos Therapeutics’s Book Value Per Share?
Book value per share is 2.36
Is Alaunos Therapeutics Cash Flow Positive?
-
What Is TCRT Cash Flow From Operations?
Cash flow from operations (TTM) is -$17.4M -
What Is Alaunos Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $0 -
What Is Alaunos Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $1.5M
Alaunos Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
TCRT return on invested capital is -189.69% -
What Is Alaunos Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -144.17% -
What Is TCRT Return On Equity?
ROE is a measure of profitability and is -189.69%
Alaunos Therapeutics Earnings Date & Stock Price
-
What Is Alaunos Therapeutics's Stock Price Today?
A single share of TCRT can be purchased today for 3.12 -
What Is Alaunos Therapeutics’s Stock Symbol?
Alaunos Therapeutics trades on the nasdaq under the ticker symbol: TCRT -
When Is Alaunos Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Alaunos Therapeutics is scheduled on November 14, 2024 -
When Is TCRT's next ex-dividend date?
Alaunos Therapeutics's next ex-dividend date is September 24, 2024 -
How To Buy Alaunos Therapeutics Stock?
You can buy Alaunos Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Alaunos Therapeutics Competitors
-
Who Are Alaunos Therapeutics's Competitors?
Below is a list of companies who compete with Alaunos Therapeutics or are related in some way:
Alaunos Therapeutics Dividend Yield
-
What Is TCRT Dividend Yield?
Alaunos Therapeutics’s dividend yield currently is 0% -
What Is Alaunos Therapeutics’s Payout Ratio?
Alaunos Therapeutics’s payout ratio is 0% -
When Did Alaunos Therapeutics Last Pay A Dividend?
The latest dividend pay date is September 24, 2024 -
What Is Alaunos Therapeutics’s Dividend Per Share?
Alaunos Therapeutics pays a dividend of $0.00 per share
Alaunos Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -279.87% |
Revenue: | 0% | 0% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 1 |
Sell Recommendations: | 0 |
Price Target: | 205.50 |
Upside from Last Price: | 6486.54% |